Access cutting-edge relapsed/refractory acute myeloid leukemia (aml) treatment through this clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Duarte location
Preparing your pre-screening questions…
Access relapsed/refractory acute myeloid leukemia (aml) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related relapsed/refractory acute myeloid leukemia (aml) treatment provided free
Check if you qualify for this relapsed/refractory acute myeloid leukemia (aml) clinical trial in Duarte, CA
No-Cost Study Care
Local to Duarte
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Every patient responds differently to their cancer treatment, and some treatments work better for some patients more than others. For patients with relapsed, refractory ( R/R) AML, there may be fewer approved treatment options remaining. In this research study, the investigators are testing whether high throughput drug screening (HTS) in combination with robust molecular testing by HopeSeq (includes DNA sequencing for \>500 genes and 160 gene rearrangements and RNAseq for \>5,000 genes) can help doctors determine which treatment might work best for each individual patient. HTS tests how the patient's own AML cells respond to different treatment options including individual drugs and triple drug regimens and recommends for the best treatment options for an individual patient. Participants will provide extra bone marrow and/or blood at the time of routine procedure, and these extra sample(s) will be tested using the Cancer Drug Sensitivity Test ( CDST) HTS, CLIA approved in Washington state since 2014. A committee (the Functional Molecular Tumor Board) will review the HopeSeq and HTS results, past treatments, and clinical description, and give a recommendation for the best AML treatment options for each individual patient. The patient's doctor will get a copy of the recommendation and discuss treatment options with the patient. The patient and their doctor will decide on the best treatment plan for the patient, one which will be approved by insurance. Patients will not be treated with any drugs as part of this study. Then at 6 and 12 months, there will be retrospective review of medical records to determine how will the testing predicted the response, drug sensitivity or resistance, and overall and disease-free survival will be monitored.
Sponsor: City of Hope Medical Center
Yes, this clinical trial (NCT07613385) has an active research site in Duarte, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for relapsed/refractory acute myeloid leukemia (aml) treatment options in Duarte, CA, this clinical trial (NCT07613385) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Duarte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced relapsed/refractory acute myeloid leukemia (aml) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all relapsed/refractory acute myeloid leukemia (aml) clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Duarte — not just this study.
Browse Leukemia Trials in Duarte →